Drug
Palbociclib
Data on this page refer exclusively to patients treated with
Palbociclib combined with SBRT, without concurrent use of
drugs from other classes.
Combination therapy data and pooled group-level evidence are available on the
CDK4/6 inhibitor group page.
Drug Profile
| Therapeutic Class | Targeted Therapy |
| Drug Class | CDK4/6 Inhibitors |
| Group | CDK4/6 inhibitor |
| Mechanism of Action | CDK4/6 inhibitor |
| Half-life | 29 h |
